output publications or other works Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human ß c ells against proinflammatory insults Conference Paper Screening of metabolism disrupting chemicals diabetogenic activity on pancreatic ¿ and ß cells using in vitro methods Conference Poster
